Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT01706393
Eligibility Criteria:
Inclusion Criteria:
* Patients who current diagnosis of gynecologic cancer or rectal cancer and never previously received radiation therapy and will use for the first time radiotherapy at department of radiation oncology, Seoul National University Hospital.
* ECOG performance status (PS) of 0, 1, or 2.
* signed written informed consent.
* Patients who get pelvic/abdominal radiotherapy.
Exclusion Criteria:
* People who use antibiotics that can affect intestinal microorganism growth within one month before the study.
* Patients who use probiotics within one month before the study.
* Patients received neoadjuvant chemotherapy.
* Acute enteritis symptoms (diarrhea, abdominal pain, nausea, vomiting) for the patient.
* Patients diagnosed with inflammatory bowel disease.
* Patients suspected gastrointestinal infections and other infectious diseases.
* Suspected infections from blood tests : Excessive rise in WBC, ESR, CRP
* Suspected renal insufficiency from blood tests
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01706393
Study Brief:
Protocol Section:
NCT01706393